APLS earnings: a positive outcome, +5.4%

On February 21, 2023, Apellis Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.4% in the window around the event. It had already run +6.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.